![](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_213,h_300/https://aimconnection.eu/wp-content/uploads/2024/03/Adding-RD-to-Portfolio-Cover-Shot-2024-213x300.png)
White Papers
March 22, 2024
Adding (Ultra-) Rare Disease Products to Your Company’s Portfolio: It’s a Whole New “Ball Game”
Interest in rare disease (RD) therapies continues to rise, with many established companies incorporating RD therapies into their portfolios for the first time. This paper:
- Describes the special challenges associated with distributing RD products
- Outlines the key steps and deliverables for developing and implementing supply chains for RD therapies
- Summarizes the pitfalls that biopharma companies must avoid when working to establish reliable supply chains in rare diseases.